Questions For Our Attorneys?
We stand for our clients.Call us today: (855) 264-6270

Jayne Conroy


112 Madison Avenue, 7th floor
New York, New York

Practice Areas:

  • Mesothelioma & Asbestos
  • Pharmaceutical Litigation

Bar and Court Admissions:

  • Massachusetts, 1985
  • U.S. District Court, District of Massachusetts, 1986
  • U.S. Court of Appeals, First Circuit, 1986
  • U.S. District Court, District of Columbia, 1997
  • New York, 1996
  • U.S. District Court, Southern and Eastern Districts of New York, 1996
  • U.S. District Court, District of Columbia and U.S. Court of Federal Claims, 2003
  • U.S. District Court, Southern District of Illinois, 2004


Jayne Conroy

Rated by Super Lawyers

loading …

  • New York Metro Super Lawyer, 2010 – 2016
  • Best Lawyers: “Best Lawyers in America” in 2018 in the area of Plaintiffs’ Mass Tort Litigation/Class Actions
  • Inducted into the National Trial Lawyers Association’s “Trial Lawyer Hall of Fame” in 2019

Speaking Engagements:

  • Federal Bar Council (Panelist on Trial Advocacy, Winter Bench & Bar Conference, 2001, 2003)
  • New York County Lawyers Association (CLE Instructor on Trial Advocacy 2000, 2001)
  • American Association for Justice; Co-Chair, Mealey’s Asbestos and Bankruptcy Seminar (2001)
  • Lecturer, National Law Journal Litigation Summit (2002)
  • Panelist, Mealey’s Pharmaceutical Lawyers’ SuperConference (2008)
  • Panelist, ABA 2008 Pharmaceutical CLE Workshop.

Representative Experience:

Pharmaceutical Litigation


  • The Association of the Bar of the City of New York
  • New York State Bar Association (Chair, Products Liability Committee, 2002 to 2004)
  • Massachusetts Bar Association
  • Federal Bar Council
  • American Association for Justice


  • Dartmouth College (B.A., 1980)
  • New England School of Law (J.D., 1985). Editor, New England Journal on Criminal & Civil Confinement, 1984-85.

As a named shareholder of Simmons Hanly Conroy, Ms. Conroy is an experienced litigator who has developed a superb national reputation as a skilled strategist, trial lawyer and negotiator over her thirty year career. For many years, Ms. Conroy acted as national trial and coordinating defense counsel to a multi-national corporation and several of its subsidiaries. In recent years, she has represented plaintiffs exclusively in a wide variety of products liability matters.

Ms. Conroy’s practice currently focuses on various complex civil cases, including a high profile sex abuse case against multiple Catholic institutions and litigation against Volkswagen on behalf of several thousand plaintiffs who were affected by the German automaker’s recent emissions scandal.

Ms. Conroy has a track record for standing up for the rights of individuals and families harmed by corporate wrongdoing. She has recovered millions in verdicts and settlements for those injured by unsafe consumer products, including victims of 9/11, families impacted by Toyota’s recent unintended acceleration malfunction, and thousands of young women who suffered heart attacks and other cardiovascular injuries as a result of taking Yaz, a heavily marketed birth control manufactured by the Bayer corporation. She currently represents multiple individuals who were injured by DePuy artificial hips and pelvic repair system materials.

Protecting Rights of Patients Injured by Hip Implants

In 2016, Ms. Conroy helped secure a staggering $1 billion Texas federal jury verdict in the third bellwether trial involving Johson & Johnson’s DePuy Pinnacle Hip Implant. The trial consolidated 6 plaintiffs’ cases and the verdict came after key findings were presented, including information that Johnson & Johnson aggressively promoted the DePuy device through kickback payments to surgeons. This verdict followed a $502 million verdict awarded earlier in the year on behalf of five plaintiffs in the U.S. District Court for the Northern District of Dallas Division. In this trial, Ms. Conroy presented ground-breaking evidence of instances in which surgeons lied about clinical results and forged consent forms for patients implanted with the product. The fourth bellwether trial is scheduled for later in 2017.

Litigating on Behalf of Volkswagen Owners and Dealers

A member of the Volkswagen MDL Plaintiffs’ Executive Committee, Ms. Conroy has been on the front lines of this litigation. In 2016, she helped secure a $14.7 billion global settlement on behalf of 2.0-liter diesel Volkswagen and Audi vehicle owners.

Ms. Conroy also leads the firm’s efforts in representing dealers who were in competition with Volkswagen and lost sales as a direct result of the company’s misleading advertising efforts and falsified emissions reports.

Fighting the Opioid Epidemic

Ms. Conroy and fellow Shareholder Paul Hanly filed cases in 2016 on behalf of New York counties facing an opioid epidemic. The lawsuits allege the opioid manufacturers caused the epidemic through deceptive marketing campaigns misrepresenting the dangers of long-term prescription opioid use. New York counties incurred millions in costs related to healthcare, criminal justice and victimization, and lost productivity because of the epidemic.

Helping Victims of Sexual Abuse

In 2013, Ms. Conroy helped achieve a landmark settlement of $12 million on behalf of 24 Haitian boys at an orphanage in Haiti who were sexually abused by convicted pedophile Douglas Perlitz. She has since filed over 100 additional cases on behalf of other victims. Claims in all the cases involve improper supervision of Perlitz’s activities as he operated the school for underprivileged boys in Cap Haitien, Haiti, from the late 1990s until around 2010, during which time Perlitz raped and otherwise sexually abused the victims. In 2011, Perlitz was convicted of sexual abuse and currently is serving a 19-year, seven-month federal prison sentence in Seagoville, Texas. The settlement was paid by the Society of Jesus of New England; Fairfield University; the Order of Malta; Hope Carter, a volunteer at the Haitian facility; and Father Paul Carrier.

Standing with Victims of 9/11

Ms. Conroy has represented several thousand victims of the September 11, 2001 tragedy in a multidistrict action against the financial sponsors of terrorism. Representing nearly 3,000 of the September 11 victims who died on that day, Ms. Conroy and Simmons Hanly Conroy continue to file claims against financial sponsors and the government of Saudi Arabia, and other alleged charities which supported the acts of terror committed by directly providing funds from the Middle East to the hijackers involved. In a separate set of negligence litigations against the airlines and airport security companies on behalf of 50 families who lost their loved ones on the four 9/11 aircrafts, Ms. Conroy helped forge settlements that totaled in the hundreds of millions of dollars.

Litigation to Keep Products Safe

Ms. Conroy serves or has served as a member of Plaintiffs’ Steering or Executive Committees in nearly a dozen multidistrict pharmaceutical litigations. Since 2006, she is credited with orchestrating the settlements of thousands of pharmaceutical cases for a total recovery for the firm’s clients that exceeds $800 million. Throughout much of 2008, Ms. Conroy was engaged in negotiating the terms of the landmark, $894 million settlement of Bextra and Celebrex cases against Pfizer.

In 2015, The National Law Journal named Ms. Conroy as one of the nation’s Outstanding Women Lawyers. She and the other honorees were selected based on independent investigations and represent the most accomplished female attorneys working in the legal profession today, according to the publication. Ms. Conroy is also nationally renowned as a speaker on trial advocacy and regularly sits on panels of experts at national litigation conferences.

Ms. Conroy resides in New York City and Cape Cod.

Representative Cases Include

  • $1 Billion DePuy Hip Verdict | In Re:  DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 13-3631, Rosa Metzler, et al. v. DePuy Orthopaedics, Inc., et al., No. 12-2066, Michael Weiser v. DePuy Orthopaedics, Inc., et al., No. 13-3631, Judith Rodriguez v. DePuy Orthopaedics, Inc., et al., No. 13-3938, Linda Standerfer v. DePuy Orthopaedics, Inc., et al., No. 14-1730, Kathleen Davis, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-1767, Marvin Andrews, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-3484. (Six cases consolidated for trial in the U.S. District Court for the Northern District of Dallas Division alleging injuries from J&J DePuy Pinnacle metal-on-metal hip implants.) (Co-counsel and member of the Plaintiffs’ Executive Committee);
  • $502 million DePuy Hip Verdict | Aoki v. DePuy Orthopedics, et al., No. 3:13-cv-01071-K; Christopher v. DePuy Orthopedics, et al., No. 3:14-cv-01994-K; Greer v. DePuy Orthopedics, et al., No. 3:12-cv-01672-K; Klusmann v. DePuy Orthopedics, et al., No. 3:11-cv-02800-K; and Peterson v. DePuy Orthopedics, et al., No. 3:11-cv-01941-K. (Five cases consolidated for trial in the U.S. District Court for the Northern District of Dallas Division alleging injuries from J&J DePuy Pinnacle metal-on-metal hip implants; verdict of $502 million including $142 million compensatory and $360 million punitive damages.)
  • MDL No. 2672, In Re: Volkswagen “Clean Diesel” Marketing, Sales Practices, And Products Liability Litigation (court-appointed member of the Plaintiffs’ Executive Committee)
  • Jean-Charles v. Perlitz, 3:11-CV-00614-RNC (D. Conn. 2013) (consolidated actions on behalf of 24 Haitian nationals alleging negligent supervision on part of Connecticut-based defendants of convicted pedophile, resulting in sexual abuse; settlement of $12 million);
  • In re Toyota Motor Corp. Unintended Acceleration Marketing, Sales Practices, and Product Liability Litigation, MDL 2151 (C.D. Cal.) (court-appointed member of Lead Counsel Committee for Economic Loss Claims);
  • In re Terrorist Attacks on September 11, 2001, No. 21 MC 97 (S.D.N.Y.) (consolidated 9/11 negligence actions against airlines and airport security companies);
  • MDL 1570, In re Terrorist Attacks on September 11, 2001 (S.D.N.Y.) (Anti-terrorism Act actions against financial sponsors of terrorism);
  • In re DePuy Pinnacle Hip Implant Products Liability Litigation, MDL 2244 (N.D. Tex. Jan. 9, 2012) (court-appointed member of Plaintiffs’ Executive Committee);
  • In re DePuy ASR Hip Implant Products Liability Litigation, MDL 2197 (N.D. Ohio) (court-appointed member of Plaintiffs’ Steering Committee);
  • In re Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf Of Mexico, on April 20, 2010 litigation, MDL 2179 (E.D. La.) (co-chair of Environmental Testing Committee);
  • In re Syngenta AG MIR162 Corn Litigation, MDL 2591 (D. Kan. Jan. 21, 2015) (court-appointed member of Plaintiffs’ Executive Committee);
  •  In re Lipitor Products Liability Litigation, MDL 2502 (D.S.C. April 9, 2014) (court-appointed member of Plaintiffs’ Executive Committee);
  •  In re Zoloft Products Liability Litigation, MDL 2342 (E.D. Pa. 2012) (court-appointed member of Plaintiffs’ Steering Committee);
  •  In Re Propecia (Finasteride) Product Liability Litigation, MDL 2331 (E.D.N.Y. 2012) (court-appointed member of Plaintiffs’ Steering Committee);
  •  In re Pelvic Repair System Products Liability Litigation, MDL 2325, 2326 & 2327 (S.D. W. Va. 2012) (court-appointed member of Plaintiffs’ Steering Committee);
  •  In re Actos Products Liability Litigation, MDL 2299 (W.D. La. 2012) (court-appointed member of Plaintiffs’ Steering Committee);
  •  In re Yazmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL 2100 (S.D. Ill.) (court-appointed co-chair of Plaintiffs’ Law and Briefing Committee);
  •  In re Chantix (Varenicline) Products Liability Litigation, MDL 2092 (N.D. Ala.) (court-appointed Plaintiff State and Federal Court Co-Liaison);
  •  In re Gadolinium-Based Contrast Agents Products Liability Litigation, MDL 1909 (N.D. Oh.) (court-appointed member of Plaintiffs’ Steering Committee);
  •  In re Zyprexa Litigation, MDL 1596 (E.D.N.Y.) (court-appointed member of Plaintiffs’ Executive Committee);
  •  In re Bextra and Celebrex Products Liability Litigation, MDL 1699 (N.D. Cal.) and New York State Coordinated Proceedings (court-appointed member of Discovery and Science Committees, Trial Team and Common Benefit Allocation Committee);
  •  Owens-Illinois, Inc. v. T&N Ltd. , 191 F.R.D. 522 (E.D. Tex. 2000) (successful vacation of $1.66 billion default judgment);
  •  Chase Manhattan Bank v. T&N plc, 1997 WL 221203 (S.D.N.Y. Apr. 28, 1997), aff’d, 162 F.3d 1147 (2d Cir. 1998) (successful defense of largest asbestos property damage case ever tried in U.S.) (trial profiled in “Chase’s Case Turns to Dust,” The American Lawyer (May 1996)); and
  •  Prudential Ins. Co. v. T&N plc (D. Mass. 1992) (successful defense of $200 million asbestos property damage action).